1/47
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced | Call with Kai | Chat |
|---|
No analytics yet
Send a link to your students to track their progress
Drug absorption differences in women
longer gastric emptying time
absorption affected by estrogen
lower levels of alcohol dehydrogenase
Drug distribution difference in women
lower body weights and BMIs
higher proportion of fats, lipophilic drugs more absorbed
lower levels of circulating lipophilic drugs
Fiber and estrogen PMS
fiber rich diet with less than 20% calories from fat can lower estrogen and curb side effects
Meds for PMS and PMDD
alprazolam (benzo), danezol (androgen), ibuprofen, SSRIs, herbals (primrose oil, chaste tree berry, calcium and magnesium salts, vitamin E, B
Herbals that can cause AUB
garlic, gingko bilboa, ginseng, soy, st johns wort
dysfunctional uterine bleeding treatment
correct volume status
IV conjugate estrogen therapy or PO for nonsevere cases
ADRS of high dose estrogen
N/v, HA, fluid retention, thrombosis, MI, stroke
caution for estrogen
liver disease, over 35 and smoking or previous thromboembolic event or estrogen dependent tumor
Treatment for heavy bleeding
levonorgestrel IUD called Mirena
Endometrial hyperplasia without atypica tx
cyclic or continuous progestins
OCP and cervical cancer
they DO NOT reduce the risk of cervical cancer
Estrogen and FSH
suppresses release of FSH and LH until ovulation when it is released
when does progesterone rise
after ovulation
OCP dose goal
lowest amount tolerated
Low dose monophasic OCP
allows menses 4x/year, breakthrough bleeding possible
multiphasic pills
used for regular monthly cycles
best used for treating menstrual migraines
more likely to have breakthrough bleeding
progesterone only pills
affected only when taken strictly at same time
do not suppress HPA axis
no withdrawal breaks
COCP
combine estrogen and progestin
suppress HPA axis to prevent ovulation
monthly withdrawal bleeding
low dose COCP
may be used in continuous cycle with 2-3 months on and then one week off for bleeding to occur
estrogen containing OCP contraindications
hx of CVA, migraine with aura, heart or liver disease, estorgen sensitive cancers, clotting disorders, DVT, Factor V, undiagnosed uterine bleeding or high breast cancer risk
estrogen and progesterone components dosing
estrogen in mcg and progesterone in mg
estrogens commonly used in BC
Mestranol, ethinyl estradiol and estropipate
progesterones commonly used in BC
levonorgestrel, norgestimate, norethindrone, desogestrel, and drospirenone, ethynodiol diacetate, medroxyprogesterone and entonogestrel
estrogen effects
suppresses FSH
potentiate progestin to suppress LH to halt follicle growth
stabilize endometrial lining
inhibits ovulation by suppression of FSH and LH
inhibition of implantation in high dose form
Progestins MOA
halts follicle growth
hostile cervical environment to hampers sperm
implantation inhibition
alters mid cycle surge of FSH and LH to prevent ovulation
COC uses
cycle regulation, contraception, acne relief, headaches
Estrogen excess adrs
nausea, edema, cramps, depression
lactation suppression, breast tenderness, CVA
thrombosis, hepatic adenoma, weight gain
estrogen deficiency adrs
hot flashes, spotting, decreased libido, drug vaginal mucosa and depression
progestin excess adrs
fatigue, HTN, decreased libido, acne, weight gain, hair loss
progestin deficiency adrs
breakthrough bleeding, heavy flow, weight loss, dysmenorrhea, delayed menses onset
general adrs of OCP
hypercoag, liver abnormalities, stimulation of estrogen sensitive cells
Black box warning for COC
women over 35 who smoke increases serious CV events
OCP interactions/increase metabolism
interferes with tamoxifen
anticonvulsants
PO antibiotics like penicillins
rifampin
St johns wort
griseofulvin
Transdermal contraceptive
contain estrogen and progesterone like ortho evra
transdermal contraceptive moa
thickening of cervical mucus
regulation of period
increased risk of thromboembolism
NO first pass metabolism, less interactions
lower doses required
transdermal contraception adrs
contact dermatitis, skin hyperpigmentation and irritation
transdermal contraception education
replaced weekly
3 weeks on one week off for bleeding
less reliable in women over 200 pounds
breakthrough bleeding more common with this method over PO
Injectable Contraceptives
progestin only for 2 months or combined effective for 1 month
injectable progestin only MOA
thickens cervical mucus
NOT for IV, only IM
injectable contraceptives adrs
progestin only-no CV events, acne, liver toxicity, decreased libido, elevated BP
Disadvantages of injectables
pain, weight gain and irregular menses, decreased bone density
injectables and wash out period
period of 4 weeks before elective surgery, wait 2 weeks to restart after sx
progestin only protective effects
PID, seizurea, myoma and endometriosis
Depo Provera Shot
progestin only injection taken once every 12 weeks; .3% typical and perfect; higher rate of amenorrhea, spotting, weight gain, mood swings; longer return to fertility
subdermal implantable contraceptives
progesterone agents with no first pass, effective for 3 years
subdermal implant adrs
irregular bleeding, weight gain, acne
intravaginal Rings
NuvaRing 35 days of active use, ethinyl estradiol and etonogestrel, suppresses ovaries locally
spermacide do nots
nonoxynol-9 active agent, do not use in patients with HIV exposure